Validation of a fast and effective Corona diagnostic test for the healthcare system
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB - RISE Biologisk funktion, Borås |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | May 2020 - October 2020 |
| Status | Completed |
| Venture | Innovations to mitigate the crisis |
| Call | Finding new ways in the time of a crisis |
Important results from the project
We have validated the process for analysis of SARS-CoV2 in field from sampling, documentation, sample handling, virus inactivation and analysis. We did not succeed in achieving the goal of 1 hour response time but ended up under the project in 2 hours, which is lower than what we strived for but still acceptable in clinical aspect and equivalent to the leading competitors. We will, after the project, continue with the prepared work process and apply it to different patient categories with implementation Q1 2021.
Expected long term effects
We have established a process for analysis of SARS-CoV2 in the field, which includes sampling, documentation, sample management, virus inactivation and analysis. After the project, this will be implemented on different patient categories during Q1 2021. We have identified opportunities for improvement of the PATHPOD instrument, which after updating will lead to the possibility of using the instrument in the field.
Approach and implementation
The project has been carried out according to the project plan. A clinical study has been conducted with testing of SARS-CoV2 with the portable instrument PATHPOD in comparison with the standard method RT-qPCR and a complementary instrument on the market. The process for sampling, documentation, sample handling, virus inactivation and analysis has been successfully validated and the process will be implemented on different patient categories during Q1 2021.